Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Next generation robotic surgery: robotic vision based safe endoscopic spine surgery

Project description

Robot surgeons for spinal endoscopy

In the past decade, the field of spinal surgery has benefited greatly from technological advancements – from diagnostic imaging and 3D printing to robotic surgery. With the speed of technological innovation increasing, robot-assisted surgery has allowed doctors to perform complex procedures with more precision. The EU-funded X-BONECUT project is taking robot-assisted surgery to the next level, developing a surgical robot that does not need assistance. Its robot is fitted with 'eyes' to aid in decision making. Coordinated by Spain’s Deneb Medical, the project is developing the first surgical robot tailored to perform endoscopic lumbar surgery while limiting the risk of unintended damage to the duramater and nerves. Its robot will also reduce surgery time and cut hospital costs.

Objective

All surgical robotic solutions available in the market today are precise manipulators rather than robots, as none of them takes its own decisions nor does automatize any process. For surgical robotics to make the next paradigm change, the ability for the robots to take their own decisions must be developed. To take their own decisions, they need to be aware of the environment where they are working. In other words: they need to have robotic eyes. This is exactly what Deneb Medical (DM) is developing with its X Platform. This surgical robotic platform approach enables multiple market applications, for which Deneb Medical has defined a product pipeline. The first product in this pipeline is DM’s X-BoneCut.
Today the most important surgical problem, is the elimination of surgical unintended damage. DM’s X-BoneCut will be a surgical robot tailored to perform endoscopic lumbar surgeries in a safe and fast way, eliminating the risk of surgical unintended damage to duramater (incidental durotomy) and nerves, reducing overall surgery time and with an easy learning curve. X-BoneCut will add to private and public health institutions up to 7B$ in value in EU and US, as it will help reduce total average direct costs to hospitals in 7B$.
DM’s business model is based on the development, manufacturing and sale of the robot and its disposable. The revenue model includes the sale to the distributor of a) the robotic system b) the disposable needed to perform surgeries with it and c) the robot’s maintenance contract. DM’s strategy is to install a big number of robots and supply the disposables, so the revenue portion of the disposable will increase throughout the years.
X-BoneCut is based on a DM’s already patented technology and DM knows no competitor that is developing a similar device with a similar functionality. Further DM is working on 3 additional patent applications that will help create stronger competitive advantages, not only for the short but also for the longer term.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

SME - SME instrument

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

DENEB MEDICAL, SL
Net EU contribution
€ 2 103 193,40
Address
PASEO MIRAMON 170
20014 San Sebastian
Spain
SME
Yes
Region
Noreste País Vasco Gipuzkoa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 3 098 377,00